Setback: AstraZeneca nasal spray COVID vaccine fails in early trial Ruchika Sharma11 Oct 2022 3:33 PM ISTThe immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.
AstraZeneca India, CAPED Trust launch 'Ganga Godavari Cancer Screening Program' in Mathura Ruchika Sharma5 Oct 2022 9:00 AM ISTFacilitated by Charities Aid Foundation (CAF) India, the primary aim of the program is to create cancer awareness, and detect oral, breast and...
AstraZeneca Rare Disease, Alexion to acquire LogicBio Therapeutics to accelerate growth in Genomic Medicine Ruchika Sharma4 Oct 2022 11:45 AM ISTAlexion, through a subsidiary, will initiate a cash tender offer to acquire all outstanding shares of LogicBio for $2.07 per share.
AstraZeneca severe asthma treatment Tezspire gets Japanese nod Ruchika Sharma28 Sept 2022 3:37 PM ISTUK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or...
AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis Ruchika Sharma25 Sept 2022 12:00 PM ISTUltomiris (ravulizumab), the first and only long-acting C5 complement inhibitor, offers immediate, complete and sustained complement inhibition.
AstraZeneca Severe Asthma treatment Tezspire gets nod in EU Ruchika Sharma22 Sept 2022 2:00 PM ISTTezspire (tezepelumab) is being developed by AstraZeneca in collaboration with Amgen.
AstraZeneca Evusheld approved in EU for treatment of COVID Ruchika Sharma20 Sept 2022 2:30 PM ISTThe recommended dose of Evusheld for treatment in Europe is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
EMA Committee recommends nod of Sanofi, AstraZeneca Beyfortus for prevention of RSV disease in infants Ruchika Sharma18 Sept 2022 3:00 PM ISTParis: Sanofi and AstraZeneca have recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
AstraZeneca Evusheld recommended for approval in EU for treatment of COVID-19 Ruchika Sharma17 Sept 2022 3:30 PM ISTThe recommended dose of Evusheld for treatment in the EU is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
AstraZeneca unveils iPHARMACY to up-skill pharmacists across India Ruchika Sharma15 Sept 2022 12:00 PM ISTThe program will focus on inventory management, good pharmacy practices, customization of pharmacy for patient of future, and management of pharmacy...
AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures Ruchika Sharma13 Sept 2022 4:00 PM ISTUS District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
